Abstract 3422: Combined treatment with interleukin-4 receptor-targeted cytotoxic peptide and PD-L1-blocking peptide efficiently induces immunogenic cell death of tumor cells and activates T-cell activity - KIVIRID

Abstract 3422: Combined treatment with interleukin-4 receptor-targeted cytotoxic peptide and PD-L1-blocking peptide efficiently induces immunogenic cell death of tumor cells and activates T-cell activity

Authors: Nawon Park, Byungheon Lee, Hyunsu Lee

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-3422

Source: Full article

Abstract

Abstract